Patents by Inventor Susmita Borthakur

Susmita Borthakur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tissue targeted immunotolerance with a CD39 effector
    Patent number: 11981715
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: May 14, 2024
    Assignee: Pandion Operations, Inc.
    Inventors: Daniel Rios, Purvi Mande, Joanne L. Viney, Nathan Higginson-Scott, Kevin Lewis Otipoby, Susmita Borthakur, Salvatore Alioto, Lindsay J. Edwards
  • TISSUE TARGETED IMMUNOTOLERANCE WITH PD-1 AGONISTS OR IL-2 MUTEINS
    Publication number: 20230235004
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: February 19, 2021
    Publication date: July 27, 2023
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Joanne L. VINEY, Nathan HIGGINSON-SCOTT, Kevin OTIPOBY, Daniel RIOS, Susmita BORTHAKUR, Salvatore ALIOTO, Lindsay EDWARDS
  • TISSUE TARGETED IMMUNOTOLERANCE WITH A CD39 EFFECTOR
    Publication number: 20210269496
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.
    Type: Application
    Filed: February 18, 2021
    Publication date: September 2, 2021
    Inventors: Daniel Rios, Purvi Mande, Joanne L. Viney, Nathan Higginson-Scott, Kevin Lewis Otipoby, Susmita Borthakur, Salvatore Alioto, Lindsay J. Edwards